AKT2 and breast cancer: Expression of both PIPP and AKT1 was reduced in a subset of human breast cancers and it is interesting to speculate that hyperactivated AKT2 in these tumours may promote metastasis leading to a poorer outcome [105] although this has yet to be shown.